Recruiting

NCT Number: NCT07418385

Voluntary HIV Screening in the General Population in France

Since 2020, an increase in positive screenings for sexually transmitted infections, including HIV, has been observed.

Voluntary early screening plays an important role in the national strategy for HIV care in France. There are currently several methods that allow patients to undergo voluntary screening.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Human Immunodeficiency Virus (HIV) Acquired Immunodeficiency Syndrome Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ufr Medecine Urca

Reims, 51100, France

Location status: Recruiting

Location contact

Coralie Barbe

CONTACT

[email protected]

326913665 ext. +33

About this study

Objectives

The main objective is to describe the voluntary HIV screening methods used by the general population in France.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
Male or female
Regardless of sexual orientation
Whether or not they have previously undergone voluntary HIV testing
Agreeing to participate in the study.

Exclusion criteria

Minors
Refusing to participate in the study

Treatment and study plan

Data collections

Other

data collections

Primary outcomes

The method(s) used for undergoing voluntary HIV testing questionnaire

Time frame: Day 0

The method(s) used for undergoing voluntary HIV testing: medical prescription, Center for Free Information, Testing, and Diagnosis, medical laboratory, rapid diagnostic test (RDT), or self-test

Study contacts

Contact information is provided by the study sponsor or research team.

Gestonnairedu CURRS

CONTACT

[email protected]

0326918822 ext. +33

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: depistageVIH

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Feb 18, 2026
Registry last updated: Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting